50,441 - 50,460 of 112,425 Results

  • Sex-Selective Abortion Ban Rejected By House

    The House on Thursday voted down a bill that would have banned abortions based on the sex of a fetus. Republicans, however, said they achieved a strategic goal of forcing Democrats to vote against it.

  • N.Y. Catholics Split On Bishops’ Lawsuit Over Contraception Rule

    In political developments, a new poll shows a significant divide among Catholics but little support among general voters in New York for the church's complaints about the Obama administration rule. Also, in Minnesota, a new candidate opens his campaign for Congress and criticizes the state's handling of Medicaid funds.

  • States Taking Sides On NYC Sugary Soda Restrictions

    A plan by New York City Mayor Michael Bloomberg to limit the sale of large sugary drinks is being met by apprehension by the food industry as other states' leaders consider what example the restrictions could provide for them.

  • House Panel Nixes Two Health Law Provisions

    The House Ways and Means Committee voted to eliminate a 2.3 percent tax on medical devices and to end a ban on the use of pretax flexible spending accounts to buy nonprescription medicines. These measures, though, are not expected to advance in the Senate even if they pass the full House.

  • Research Roundup: ACOs For Medicaid

    This week's studies come from the Archives of Internal Medicine, Journal of General Internal Medicine, Mathematica Policy Research, The Kaiser Family Foundation, The Urban Institute and other news outlets.

  • Health Law’s Medicaid Expansion, Employer Coverage Requirements Drawing Expert Analysis

    At a meeting this week, some state Medicaid directors expressed concern that their programs will not be able to handle the scheduled 2014 surge in enrollment because of challenges like outdated technology and the uncertainty of what will happen with the Supreme Court and November elections. Meanwhile, a committee of the National Association of Insurance Commissioners will offer recommendations on how to close a potential loophole in the law's employer coverage requirements.

  • First Edition: June 1, 2012

    Today's early morning highlights from the major news organizations, including reports about the latest health policy developments on Capitol Hill and news on the health insurance marketplace.

  • WHO Hopes To Host Second Meeting On Issues Related To ‘Dual-Use’ Research

    "The World Health Organization (WHO) hopes to hold a meeting late this fall to discuss 'dual-use' research issues raised in the controversy over publication of two studies involving lab-modified H5N1 viruses with increased transmissibility, a WHO official said," CIDRAP News reports. "The WHO hosted a closed meeting of disease experts and government officials Feb 16 and 17 to discuss the two H5N1 studies," CIDRAP notes, adding that "the WHO [on Wednesday] released a brief statement about its activities related to the H5N1 research controversy since the February meeting in Geneva." Keiji Fukuda, the WHO's assistant director-general for health security and environment, said, "We hope to hold a second meeting to discuss the broader concerns related to potential dual [use] research in the late fall, if resources are available," the news service notes.

  • Seriously Ill Children Administered Zinc In Addition To Antibiotics Respond Better, More Quickly To Treatment, Study Shows

    "In a newly released clinical study, conducted in India" and published in the Lancet on Thursday, "hundreds of seriously ill infants who received zinc -- an essential micronutrient for the immune system and human growth -- as well as antibiotics, responded better and more quickly to treatment than those who did not," IRIN reports, adding, "This finding is the first proof that zinc supplements may boost infant survival from infections." According to the news service, "More than 300 infants no older than 120 days (four months), hospitalized in New Delhi, the capital, for suspected meningitis (an infection of the brain or spinal cord lining), pneumonia (a lung infection) or sepsis (blood poisoning), were given zinc in addition to antibiotics" and "were found to be 40 percent less likely to experience 'treatment failure' -- needing a second antibiotic within one week of the first treatment, or intensive care or death within 21 days -- than those given a placebo."